Clinical Trial Update: Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing moxifloxacin to ceftriaxone for primary pyogenic liver abscess has completed. The study was sponsored by Kaohsiung Veterans General Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyogenic Liver Abscess

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Liver Abscess | Phase 4 | Status: COMPLETED